Antifungal Potential of Marine Organisms of the Yucatan Peninsula (Mexico) against Medically Important Candida spp.
-
Published:2023-01-06
Issue:2
Volume:28
Page:606
-
ISSN:1420-3049
-
Container-title:Molecules
-
language:en
-
Short-container-title:Molecules
Author:
Pech-Puch DawrinORCID, Grilo Diana, Calva-Pérez Susana EuniceORCID, Pedras Andreia, Villegas-Hernández HaroldORCID, Guillén-Hernández Sergio, Díaz-Gamboa Raúl, Tunjano Mateo ForeroORCID, Rodríguez JaimeORCID, Lenis-Rojas Oscar A., Jiménez CarlosORCID, Pimentel Catarina
Abstract
Invasive fungal infections represent a global health threat. They are associated with high mortality and morbidity rates, partly due to the ineffectiveness of the available antifungal agents. The rampant increase in infections recalcitrant to the current antifungals has worsened this scenario and made the discovery of new and more effective antifungals a pressing health issue. In this study, 65 extracts from marine organisms of the Yucatan Peninsula, Mexico, were screened for antifungal activity against Candida albicans and Candida glabrata, two of the most prevalent fungal species that cause nosocomial invasive fungal infections worldwide. A total of 51 sponges, 13 ascidians and 1 gorgonian were collected from the coral reef and mangrove forest in the Yucatan Peninsula (Mexico) and extracted with organic solvents. Nine crude extracts showed potent antifungal activity, of which four extracts from the sponge species Aiolochroia crassa, Amphimedon compressa, Monanchora arbuscula and Agelas citrina had promising activity against Candida spp. Bioassay-guided fractionation of the M. arbuscula extract revealed the remarkable fungicidal activity of some fractions. Analysis of the chemical composition of one of the most active fractions by UHPLC-HRMS and NMR indicated the presence of mirabilin B and penaresidin B, and their contribution to the observed antifungal activity is discussed. Overall, this work highlights marine organisms of the Yucatan Peninsula as important reservoirs of natural products with promising fungicidal activity, which may greatly advance the treatment of invasive fungal infections, especially those afflicting immunosuppressed patients.
Funder
Fundação para a Ciência e a Tecnologia
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference74 articles.
1. Watkinson, S.C., Boddy, L., and Money, N.P.B.T.-T.F. (2016). Fungi, Ecosystems, and Global Change, Academic Press. [3rd ed.]. 2. Fungi of the human gut microbiota: Roles and significance;Int. J. Med. Microbiol.,2021 3. Two unlike cousins: Candida albicans and C. glabrata infection strategies;Brunke;Cell. Microbiol.,2013 4. Invasive candidiasis;Pappas;Nat. Rev. Dis. Prim.,2018 5. Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., and Škrlec, I. (2021). Candida albicans—The virulence factors and clinical manifestations of infection. J. Fungi, 7.
|
|